YARW
Yarrow Bioscience Inc
22.50$
-6.9%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | – | – | – | 7.0% | 6.2% | – | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 93.0% | 93.8% | 97.5% | |
| 2,910.5% | 3,977.6% | 3,783.7% | 3,689.9% | 8,469.4% | 11,528.6% | 3,031.7% | 7,073.9% | 3,110.1% | 2,290.0% | 950.0% | 812.4% | 2,041.1% | |
| – | – | 3,846.9% | 1,660.6% | 2,449.6% | 3,773.8% | 1,621.3% | 3,956.5% | 1,600.6% | 1,824.6% | 3,580.2% | 2,485.6% | 2,192.3% | |
| 5,568.4% | 9,089.5% | 7,630.6% | 5,350.5% | 10,919.0% | 15,302.4% | 4,653.0% | 11,030.4% | 4,710.7% | 4,114.6% | 4,530.2% | 3,291.8% | 4,232.2% | |
| -5,468.4% | -8,989.5% | -7,530.6% | -5,250.5% | -10,819.0% | -15,202.4% | -4,553.0% | -10,930.4% | -4,610.7% | -4,014.6% | -4,437.2% | -3,197.9% | -4,134.6% | |
| -5,325.4% | -8,094.7% | -6,368.4% | -4,744.9% | -10,047.1% | -14,297.6% | -4,258.9% | -8,329.0% | -4,394.1% | -3,812.3% | -4,168.6% | -2,988.7% | -3,914.1% | |
| – | – | – | – | – | 4.8% | – | – | – | 3.1% | – | – | – | |
| -5,775.4% | -8,142.1% | -6,376.5% | -4,750.5% | -10,047.1% | -14,311.9% | -4,262.9% | -8,340.6% | -4,307.7% | -3,720.8% | -4,168.6% | -3,100.0% | -3,881.5% | |
| -5,309.6% | -8,094.7% | -6,368.4% | -4,239.4% | -10,047.1% | -14,297.6% | -4,255.9% | -8,320.3% | -4,390.5% | -3,808.5% | -4,161.6% | -2,985.6% | -3,910.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.